Navigation Links
China-Biotics, Inc. Reports Third Quarter Fiscal 2010 Financial Results
Date:2/10/2010

2009 2009 ASSETS Current assets Cash and cash equivalents $151,078,604 $70,824,041 Accounts receivable 22,779,039 14,428,382 Other receivables 766,385 6,493 Inventories 1,204,149 563,853 Amount due from a director 2,374,172 -- Prepayment 5,169,721 1,547,582 Total current assets $183,372,070 $87,370,351 Property, plant and equipment and land use right 39,021,467 33,079,839 Deferred tax assets 298,833 354,157 Total assets $222,692,370 $120,804,347 LIABILITIES AND STOCKHOLDERS' EQUITY Current liabilities Accounts payable $6,004,849 $2,909,898 Tax payables 29,006,801 25,528,447 Other payables and accruals 1,555,535 1,517,753 Amount due to a director -- 2,380,007 Total current liabilities $36,567,185 $32,336,105 Non-current liabilities Convertible note, net of discount of $3,704,118 and $6,000,054 as of December 31, 2009 and March 31, 2009 respectively $21,295,882 $18,999,946 Embedded derivatives 8,908,000 2,660,000 Interest payable 2,660,533 1,411,942 Total non-current liabilities $32,864,415 $23,071,888 Commitments and contingencies Stockholders' equity: Common stock (par value of $0.0001, 100,000,000 shares authorized, 41,461,004 shares issued and 17,080,000 outstanding as of M
'/>"/>
SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
2. China-Biotics, Inc. Launches Shining Probiotics Protein Powder
3. China-Biotics, Inc. Receives Approval to Begin Construction on Large-Scale Manufacturing Facility
4. China-Biotics, Inc. Announces Conference Call to Discuss First Quarter FY 2008 Results
5. China-Biotics, Inc. Launches English / Chinese Corporate and Investor Relations Web Site
6. China-Biotics, Inc. Announces Rescheduling of Conference Call to Discuss Third Quarter 2008 Results
7. China-Biotics, Inc. Reports Third Quarter 2008 Financial Results
8. China-Biotics, Inc. Completes Foundation for Its New Plant
9. China-Biotics, Inc. to Present at Two Upcoming Investor Conferences
10. China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company
11. China-Biotics, Inc. Announces Conference Call to Discuss Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... Understanding the need for better quality and higher ... that currently exists in this area, ChanTest has recently ... validated ion channel and GPCR cell lines. ChanTest’s ... channels control many critical physiological functions throughout the body. ... to treat a variety of human diseases. , ...
(Date:7/10/2014)... Angeles, CA (PRWEB) July 10, 2014 ... and Bioanalytical techniques during 18-20 August, 2014 at Double ... critically review the recent developments in Analytical & Bioanalytical ... the globe. , Speaking on this occasion, Dr. Srinubabu ... Analytica Acta conference is a remarkable one in ...
(Date:7/10/2014)... On July 9 Prime Minister ... Russia,s first national "Industry" award ... is developing a unique project called MabNext . ... number of innovative drugs based on monoclonal antibodies for ... place at the International Exhibition "Innoprom 2014" in Ekaterinburg. ...
(Date:7/10/2014)... 2014   Ceres, Inc . (Nasdaq: ... today financial results for the three months ended May ... Ceres reported that the company and its ... growing season in Brazil, which concluded in June, despite ... evaluation areas for part of the growing season. Yields ...
Breaking Biology Technology:Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 2Leader in Ion Channel Research Announces Newly Validated and Re-Engineered Cells 3A Critical Review of Analytical Techniques for Improved Living Standards 2A Critical Review of Analytical Techniques for Improved Living Standards 3A Critical Review of Analytical Techniques for Improved Living Standards 4Dmitry Medvedev Presented BIOCAD the First National "Industry" Award 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 2Ceres Announces Fiscal Third Quarter 2014 Financial Results 3Ceres Announces Fiscal Third Quarter 2014 Financial Results 4Ceres Announces Fiscal Third Quarter 2014 Financial Results 5Ceres Announces Fiscal Third Quarter 2014 Financial Results 6Ceres Announces Fiscal Third Quarter 2014 Financial Results 7Ceres Announces Fiscal Third Quarter 2014 Financial Results 8Ceres Announces Fiscal Third Quarter 2014 Financial Results 9
... , SANTA CLARA, Calif., Dec. 7 Cell Biosciences, ... Inc. of Lexington, Massachusetts, a leader in sample preparation ... acquisition adds Protein Forest,s novel digital ProteomeChip(TM) product line ... protein analysis. , Protein Forest, founded in 2002, pioneered ...
... , , RESEARCH TRIANGLE PARK, N.C., ... innovative treatments for diseases of the central nervous system, today announced ... that CeNeRx,s novel compound TriRima (TM) reversibly inhibits MAO-A (monoamine ... role in the regulation of mood. TriRima is ...
... ... Pollogen received ANVISA approval to market the TriPollar Technology- the most advanced ... anti-aging products have been clinically proven the world over to be ... and non-invasive and patients enjoy visible results from the very 1st treatment. ...
Cached Biology Technology:Cell Biosciences Acquires Protein Forest 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 2Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 3Publication in Neuropsychopharmacology Confirms CeNeRx's Novel RIMA Antidepressant TriRima(TM) Selectively and Reversibly Inhibits MAO-A 4Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 2Breakthrough TriPollar Technology- the Most Advanced Anti-Aging Solution- to Launch into High Growth Brazilian Market for Aesthetic Procedures 3
(Date:7/11/2014)... the National Institute of Standards and Technology (NIST) ... more effectively, they often prove that necessity is ... case recently for M. Lorna De Leoz and ... specialization of glycomics. Glycomics is the study of ... are attached to proteins and lipids and influence ...
(Date:7/11/2014)... members to reduce aggression and gain access to scarce ... activities shows a certain pattern across the day. The ... Biology Letters . , Grooming between individuals in a ... To be groomed has hygienic benefits and is stress ... provide access to infants, mating opportunities and high quality ...
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way ... called Virtual Finger, allows scientists to move through ... synapses using the flat surface of their computer ... studies orders of magnitude more efficient, saving time, ... many areas of experimental biology. The software and ...
Breaking Biology News(10 mins):Baboons groom early in the day to get benefits later 2Virtual finger enables scientists to navigate and analyze complex 3D images 2
... was the credo of early 20th century architects making design ... biologists may be turning that on its head. New research* ... and Technology (NIST) reinforces the idea that stem cells can ... by controlling their shape. The results may be important to ...
... of Health (NIH) has awarded a five-year $23.2 million ... and the University of Medicine and Dentistry of New ... research aimed at developing drug products that could be ... Members of the Environmental and Occupational Health Sciences ...
... A protein critical in heart development may also play ... by investigators from Vanderbilt-Ingram Cancer Center and the Vanderbilt Eye ... which also is key in regulating corneal cells ... , The study, appearing in the October issue of ...
Cached Biology News:Shaping up: Controlling a stem cell's form can determine its fate 2Rutgers, UMDNJ receive $23 million to develop antidotes for chemical weapons attacks 2Protein found in heart may be target for colon cancer therapies 2Protein found in heart may be target for colon cancer therapies 3
Handles samples from from 75l to 150l...
Hybridization chamblers suitable for use with all ChIP-GLAS microarrays....
Ubiquitin Related I Sampler Kit 10 mu g each...
DNA Repair Sampler Kit 10g each...
Biology Products: